Trial NCT00210119

View at ClinicalTrials.gov 
Org. Study IDs: IB2005-25
Secondary IDs: AFR22

Last trial update was posted on 2021-11-08

MeSH Interventions

Imatinib Mesylate

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid

Other Conditions

Myeloid Leukemia, Chronic

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID